Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors

This study has been terminated.
Tobira Therapeutics, Inc.
Information provided by (Responsible Party):
Priscilla Hsue, University of California, San Francisco Identifier:
First received: November 15, 2011
Last updated: May 16, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)